Creating biodegradable microcarriers for delivering HIV medications
Design and Engineering of Biodegradable 3D Nanoprinted Microcarriers for HIV Drug Delivery
['FUNDING_OTHER'] · INFRATRAC, INC. · NIH-10709471
This study is working on new, eco-friendly ways to deliver HIV medications that are specially designed for each patient, especially kids, to make it easier for them to take their medicine and improve their treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INFRATRAC, INC. (nih funded) |
| Locations | 1 site (SILVER SPRING, UNITED STATES) |
| Trial ID | NIH-10709471 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative biodegradable microcarriers that can deliver HIV medications more effectively. By utilizing advanced 3D nanoprinting technology, the project aims to create customizable drug delivery systems tailored to individual patients' needs. This approach seeks to improve medication adherence, especially in pediatric patients, by allowing for better dosing options and new routes of administration. The research addresses current limitations in drug delivery methods, such as variability and manufacturing constraints, to enhance treatment outcomes for those living with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV, particularly children who may require specialized dosing.
Not a fit: Patients who are not living with HIV or those who do not require innovative drug delivery methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized HIV treatment options, improving patient adherence and health outcomes.
How similar studies have performed: While the approach of using 3D nanoprinting for drug delivery is innovative, similar technologies have shown promise in other areas of medicine, indicating potential for success in this novel application.
Where this research is happening
SILVER SPRING, UNITED STATES
- INFRATRAC, INC. — SILVER SPRING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FLANK, SHARON — INFRATRAC, INC.
- Study coordinator: FLANK, SHARON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.